Home :: Cancer Research for the Ozarks, Springfield, Missouri  

SWOG S1207


Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e3 Breast Cancer Study- evaluating everolimus with endocrine therapy.

Available at:

Cox Health Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Central Care Cancer Center, Bolivar, MO
Cox Medical Center, Branson, MO
Freeman Health System, Joplin, MO
Mercy Hospital Joplin, Joplin, MO
Phelps County Regional Medical Center, Rolla, MO
Mercy Clinic, Rolla, MO
Mercy Hospital, St. Louis, MO
St. Louis Cancer & Breast Institute, St. Louis, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL

For more information about this clinical trial, click here.


© OzarksCancerResearch.org - All Right Reserved. | Powered by Winnovate w360™
> Visit CoxHealth.com Visit StJohns.com